Increased Prolylcarboxypeptidase Expression Can Serve as a Biomarker of Senescence in Culture
Molecules · 2024
DOI: 10.3390/molecules29102219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Nicholas Glen Boullard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jackson Hinds Comprehensive Health Center, Jackson, MS 39216, USA. Hauptthemen laut MEDLINE: Cellular Senescence, Endothelial Cells, Biomarkers, Carboxypeptidases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Mississippi (overhead account.
Abstract (Originalsprache)
Prolylcarboxypeptidase (PRCP, PCP, Lysosomal Pro-X-carboxypeptidase, Angiotensinase C) controls angiotensin- and kinin-induced cell signaling. Elevation of PRCP appears to be activated in chronic inflammatory diseases [cardiovascular disease (CVD), diabetes] in proportion to severity. Vascular endothelial cell senescence and mitochondrial dysfunction have consistently been shown in models of CVD in aging. Cellular senescence, a driver of age-related dysfunction, can differentially alter the expression of lysosomal enzymes due to lysosomal membrane permeability. There is a lack of data demonstrating the effect of age-related dysfunction on the expression and function of PRCP. To explore the changes in PRCP, the PRCP-dependent prekallikrein (PK) pathway was characterized in early- and late-passage human pulmonary artery endothelial cells (HPAECs). Detailed kinetic analysis of cells treated with high molecular weight kininogen (HK), a precursor of bradykinin (BK), and PK revealed a mechanism by which senescent HPAECs activate the generation of kallikrein upon the assembly of the HK–PK complex on HPAECs in parallel with an upregulation of PRCP and endothelial nitric oxide (NO) synthase (eNOS) and NO formation. The NO production and expression of both PRCP and eNOS increased in early-passage HPAECs and decreased in late-passage HPAECs. Low activity of PRCP in late-passage HPAECs was associated with rapid decreased telomerase reverse transcriptase mRNA levels. We also found that, with an increase in the passage number of HPAECs, reduced PRCP altered the respiration rate. These results indicated that aging dysregulates PRCP protein expression, and further studies will shed light into the complexity of the PRCP-dependent signaling pathway in aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jackson Hinds Comprehensive Health Center, Jackson, MS 39216, USA.
- Division of Pharmacology, School of Pharmacy, University of Mississippi, Oxford, MS 38677, USA.
ORCID-Profile: Jason J Paris, Fakhri Mahdi
Förderung
- University of Mississippi (overhead account
Zitieren
APA
Boullard, N. G., Paris, J. J., Shariat-Madar, Z., & Mahdi, F. (2024). Increased Prolylcarboxypeptidase Expression Can Serve as a Biomarker of Senescence in Culture. Molecules. https://doi.org/10.3390/molecules29102219
Vancouver
Boullard NG, Paris JJ, Shariat-Madar Z, Mahdi F. Increased Prolylcarboxypeptidase Expression Can Serve as a Biomarker of Senescence in Culture. Molecules. 2024. doi:10.3390/molecules29102219
BibTeX
@article{Boullard2024,
author = {Boullard, Nicholas Glen and Paris, Jason J and Shariat-Madar, Zia and Mahdi, Fakhri},
title = {Increased Prolylcarboxypeptidase Expression Can Serve as a Biomarker of Senescence in Culture},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102219}
}
EUVIMED